NeOnc Technologies Holdings, Inc. (NasdaqGM: NTHI)
Health Care · Pharmaceuticals · US
$4.94
+17.06% today · -21.4% 1Y
NeOnc Technologies Holdings, Inc. (NasdaqGM: NTHI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $109.44M and employs 5 people.
Over the last twelve months the share price has lost 21.4%, trading between 3.01 and 12.99.
Tweenvest scores NeOnc Technologies Holdings, Inc. across four factors: quality 5/100. Its strongest factor is quality.
NTHI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $109.44M
- Revenue (TTM)
- $39.99K
- P/E
- —
- EPS
- -1.87
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $12.99
- 52-week low
- $3.01
- Avg volume (3M)
- —
- Shares outstanding
- 25.93M
- Employees
- 5
- Next earnings
- —
About NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
- Founded
- 2005
- Listed since
- Mar 26, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.